In pharmacies, the range of drugs costing up to 100 rubles has halved in three years.
[ad_1]
In 2023, the range of drugs in pharmacies decreased by 11% year-on-year, from 21.6 thousand positions in 2022 to 19.4 thousand, reports RBC with reference to data from the analytical company DSM Group. According to the publication’s calculations, the range of drugs priced at 100 rubles has decreased the most. per package, by 24% year-on-year, from 5.7 thousand to 4.6 thousand positions.
As RBC notes, the choice of cheap drugs has been declining for at least the last three years: back in 2020, the range of drugs costing up to 100 rubles. consisted of 8.8 thousand positions. These drugs are the most popular among consumers, and last year their share of pharmacy sales was 32.5% by unit. However, such drugs account for only 5.3% of sales in monetary terms. The most revenue (35.7%) for pharmacies comes from medicines costing from 100 to 500 rubles; their share in 2023 was 48.2%.
Assortment in the category of medicines costing up to 500 rubles. at the end of last year, it decreased by 5.5%, from 9.2 thousand to 8.7 thousand product items. Representation of drugs costing from 500 to 1 thousand rubles. decreased by 2.8%, from 3.2 thousand to 3.1 thousand. The range of the most expensive drugs starts from 1 thousand rubles. per package fell by 17.2%, from 3.4 thousand to 2.9 thousand.
DSM Group CEO Sergei Shulyak said that the decline in the range of inexpensive drugs began more than five years ago, including due to a glut of goods. According to him, consumers themselves began to switch to more modern and, accordingly, more expensive drugs.
Federal Antimonopoly Service back in 2016 warned The government announced the withdrawal of production of 197 cheap life-saving drugs (VED) and proposed to increase prices for cheap drugs. In the fall of 2023, pharmaceutical manufacturers criticized the Ministry of Finance’s initiative to extend excise taxes on ethyl alcohol to ethanol. According to the companies, this will provoke an increase in prices for a number of pharmaceutical substances and, ultimately, for drugs from the Vital and Essential Drugs list.
Details – in the material “Kommersant” “Inter-alcohol strife”.
[ad_2]
Source link
